Iovance Biotherapeutics, Inc.(IOVA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IOVA Iovance Biotherapeutics, Inc.

休市中 05-03 16:00:00 EDT

13.63

+0.75

+5.82%

盘后13.69

+0.06+0.44%

19:55 EDT

最高13.88	最低13.30	成交量429.28万
今开13.46	昨收12.88	日振幅4.50%
总市值38.14亿	流通市值28.75亿	总股本2.80亿
成交额5,827万	换手率2.04%	流通股本2.11亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"IOVA","market":"US","secType":"STK","nameCN":"Iovance Biotherapeutics, Inc.","latestPrice":13.63,"timestamp":1714766400000,"preClose":12.88,"halted":0,"volume":4292824,"hourTrading":{"tag":"盘后","latestPrice":13.69,"preClose":13.63,"latestTime":"19:55 EDT","volume":64155,"amount":874477.6543,"timestamp":1714780531890},"delay":0,"floatShares":210902848,"shares":279831972,"eps":-1.89,"marketStatus":"休市中","marketStatusCode":7,"change":0.75,"latestTime":"05-03 16:00:00 EDT","open":13.46,"high":13.8799,"low":13.3,"amount":58265418.360352,"amplitude":0.045023,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.89,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1714982400000},"adr":0,"adjPreClose":12.88,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":13.45,"preClose":12.88,"latestTime":"09:29 EDT","volume":22731,"amount":299217.83640599996,"timestamp":1714742943378},"postHourTrading":{"tag":"盘后","latestPrice":13.69,"preClose":13.63,"latestTime":"19:55 EDT","volume":64155,"amount":874477.6543,"timestamp":1714780531890},"volumeRatio":1.0030596325548302},"requestUrl":"/m/hq/s/IOVA/","defaultTab":"news","newsList":[{"id":"2432633991","title":"Iovance Biotherapeutics, Inc.盘中异动 快速上涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432633991","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432633991?lang=zh_cn&edition=full","pubTime":"2024-05-02 02:41","pubTimestamp":1714588880,"startTime":"0","endTime":"0","summary":"北京时间2024年05月02日02时41分，Iovance Biotherapeutics, Inc.股票出现波动，股价急速上涨5.01%。Iovance Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.63%。Iovance Biotherapeutics, Inc.公司简介：Iovance Biotherapeutics Inc 是一家临床阶段的生物制药公司，通过利用人体免疫系统识别和摧毁多种癌细胞的能力，为每位患者提供个性化治疗，开创了治疗癌症的变革性方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240502024120861ea921&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240502024120861ea921&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427882504","title":"Iovance Biotherapeutics, Inc.盘中异动 下午盘股价大跌5.26%报11.71美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427882504","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427882504?lang=zh_cn&edition=full","pubTime":"2024-04-16 01:44","pubTimestamp":1713203040,"startTime":"0","endTime":"0","summary":"北京时间2024年04月16日01时44分，Iovance Biotherapeutics, Inc.股票出现波动，股价大幅下跌5.26%。Iovance Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.25%。Iovance Biotherapeutics, Inc.公司简介：Iovance Biotherapeutics Inc 是一家临床阶段的生物制药公司，通过利用人体免疫系统识别和破坏多种癌细胞的能力，采用针对每位患者的个性化疗法，开创了治疗癌症的变革性方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404160144007920a66f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404160144007920a66f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426429751","title":"Iovance Biotherapeutics, Inc.盘中异动 临近收盘股价大涨5.01%报13.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426429751","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426429751?lang=zh_cn&edition=full","pubTime":"2024-04-12 03:43","pubTimestamp":1712864613,"startTime":"0","endTime":"0","summary":"北京时间2024年04月12日03时43分，Iovance Biotherapeutics, Inc.股票出现异动，股价快速拉升5.01%。截至发稿，该股报13.21美元/股，成交量271.65万股，换手率0.97%，振幅5.64%。Iovance Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.10%。Iovance Biotherapeutics, Inc.公司简介：Iovance Biotherapeutics Inc 是一家临床阶段的生物制药公司，通过利用人体免疫系统识别和破坏多种癌细胞的能力，采用针对每位患者的个性化疗法，开创了治疗癌症的变革性方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412034334861e5096&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412034334861e5096&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426492925","title":"Iovance Biotherapeutics, Inc.盘中异动 大幅跳水6.81%报12.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426492925","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426492925?lang=zh_cn&edition=full","pubTime":"2024-04-10 21:31","pubTimestamp":1712755894,"startTime":"0","endTime":"0","summary":"北京时间2024年04月10日21时31分，Iovance Biotherapeutics, Inc.股票出现异动，股价大幅下跌6.81%。截至发稿，该股报12.32美元/股，成交量42.8661万股，换手率0.15%，振幅3.48%。Iovance Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.15%。Iovance Biotherapeutics, Inc.公司简介：Iovance Biotherapeutics Inc 是一家临床阶段的生物制药公司，通过利用人体免疫系统识别和破坏多种癌细胞的能力，采用针对每位患者的个性化疗法，开创了治疗癌症的变革性方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404102131358b0a6e08&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404102131358b0a6e08&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420407855","title":"Iovance Biotherapeutics, Inc.盘中异动 急速拉升5.00%报14.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2420407855","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420407855?lang=zh_cn&edition=full","pubTime":"2024-03-19 00:40","pubTimestamp":1710780000,"startTime":"0","endTime":"0","summary":"北京时间2024年03月19日00时40分，Iovance Biotherapeutics, Inc.股票出现波动，股价急速拉升5.00%。截至发稿，该股报14.61美元/股，成交量331.029万股，换手率1.19%，振幅7.12%。Iovance Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.47%。Iovance Biotherapeutics, Inc.公司简介：Iovance Biotherapeutics Inc 是一家临床阶段的生物制药公司，通过利用人体免疫系统识别和破坏多种癌细胞的能力，采用针对每位患者的个性化疗法，开创了治疗癌症的变革性方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403190040017a4d735a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403190040017a4d735a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419934284","title":"Iovance Biotherapeutics, Inc.盘中异动 快速下挫5.06%报13.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419934284","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419934284?lang=zh_cn&edition=full","pubTime":"2024-03-15 03:32","pubTimestamp":1710444769,"startTime":"0","endTime":"0","summary":"北京时间2024年03月15日03时32分，Iovance Biotherapeutics, Inc.股票出现波动，股价急速下跌5.06%。Iovance Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.97%。Iovance Biotherapeutics, Inc.公司简介：Iovance Biotherapeutics Inc 是一家临床阶段的生物制药公司，通过利用人体免疫系统识别和破坏多种癌细胞的能力，采用针对每位患者的个性化疗法，开创了治疗癌症的变革性方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031503324987e79025&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031503324987e79025&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2418788061","title":"Iovance Biotherapeutics, Inc.盘中异动 早盘急速下挫5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2418788061","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2418788061?lang=zh_cn&edition=full","pubTime":"2024-03-09 00:26","pubTimestamp":1709915187,"startTime":"0","endTime":"0","summary":"北京时间2024年03月09日00时26分，Iovance Biotherapeutics, Inc.股票出现波动，股价大幅下跌5.05%。Iovance Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.40%。Iovance Biotherapeutics, Inc.公司简介：Iovance Biotherapeutics Inc 是一家临床阶段的生物制药公司，通过利用人体免疫系统识别和破坏多种癌细胞的能力，采用针对每位患者的个性化疗法，开创了治疗癌症的变革性方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240309002627861dcad1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240309002627861dcad1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417214831","title":"Iovance Biotherapeutics, Inc.盘中异动 临近午盘大幅上涨5.09%报17.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2417214831","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417214831?lang=zh_cn&edition=full","pubTime":"2024-03-07 00:42","pubTimestamp":1709743330,"startTime":"0","endTime":"0","summary":"北京时间2024年03月07日00时42分，Iovance Biotherapeutics, Inc.股票出现波动，股价大幅上涨5.09%。Iovance Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.42%。Iovance Biotherapeutics, Inc.公司简介：Iovance Biotherapeutics Inc 是一家临床阶段的生物制药公司，通过利用人体免疫系统识别和破坏多种癌细胞的能力，采用针对每位患者的个性化疗法，开创了治疗癌症的变革性方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403070042107a4a23b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403070042107a4a23b6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416214416","title":"Iovance Biotherapeutics, Inc.盘中异动 股价大涨7.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2416214416","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2416214416?lang=zh_cn&edition=full","pubTime":"2024-03-04 22:30","pubTimestamp":1709562623,"startTime":"0","endTime":"0","summary":"北京时间2024年03月04日22时30分，Iovance Biotherapeutics, Inc.股票出现波动，股价大幅上涨7.98%。Iovance Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Iovance Biotherapeutics, Inc.公司简介：Iovance Biotherapeutics Inc 是一家临床阶段的生物制药公司，通过利用人体免疫系统识别和破坏多种癌细胞的能力，采用针对每位患者的个性化疗法，开创了治疗癌症的变革性方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240304223023861dafab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240304223023861dafab&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416962112","title":"BUZZ-Iovance因FDA解除肺癌治疗试验的部分临床搁置而上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2416962112","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2416962112?lang=zh_cn&edition=full","pubTime":"2024-03-04 20:17","pubTimestamp":1709554660,"startTime":"0","endTime":"0","summary":"    3月4日 - ** Iovance Biotherapeutics   股价盘前上涨8.7%，报18.30美元 ** 该公司报告说， ，美国FDA已经解除了对其治疗一种肺癌的实验性细胞疗法注册试验的部分临床搁置。** 去年12月底，在一名患者死亡后，该机构对 。** 经审查，FDA 已批准 Iovance 恢复试验的患者招募。** IOVA 预计在 2025 年完成注册队列中约 120 名患者的入组工作 ** 截至上次收盘，股价累计上涨106.52","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2416649093","title":"Iovance Biotherapeutics, Inc.盘中异动 股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2416649093","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2416649093?lang=zh_cn&edition=full","pubTime":"2024-03-01 22:39","pubTimestamp":1709303969,"startTime":"0","endTime":"0","summary":"北京时间2024年03月01日22时39分，Iovance Biotherapeutics, Inc.股票出现波动，股价急速上涨5.03%。Iovance Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.05%。Iovance Biotherapeutics, Inc.公司简介：Iovance Biotherapeutics Inc 是一家临床阶段的生物制药公司，通过利用人体免疫系统识别和破坏多种癌细胞的能力，采用针对每位患者的个性化疗法，开创了治疗癌症的变革性方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030122393087e75446&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030122393087e75446&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2414381503","title":"Iovance Biotherapeutics Inc盘中异动 下午盘股价大涨5.00%报17.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2414381503","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2414381503?lang=zh_cn&edition=full","pubTime":"2024-02-28 03:03","pubTimestamp":1709060583,"startTime":"0","endTime":"0","summary":"北京时间2024年02月28日03时03分，Iovance Biotherapeutics Inc股票出现波动，股价大幅上涨5.00%。截至发稿，该股报17.43美元/股，成交量610.09万股，换手率2.19%，振幅7.47%。Iovance Biotherapeutics Inc股票所在的生物技术行业中，整体涨幅为0.33%。Iovance Biotherapeutics Inc公司简介：Iovance Biotherapeutics Inc 是一家临床阶段的生物制药公司，通过利用人体免疫系统识别和破坏多种癌细胞的能力，采用针对每位患者的个性化疗法，开创了治疗癌症的变革性方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022803030487e73aa1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022803030487e73aa1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2414865297","title":"Iovance Biotherapeutics Inc   预计每股亏损43美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2414865297","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2414865297?lang=zh_cn&edition=full","pubTime":"2024-02-27 06:22","pubTimestamp":1708986158,"startTime":"0","endTime":"0","summary":"   * Iovance Biotherapeutics Inc    将于2月28日公布截至2023年12月31日的财报，预计该公司的季度收入将有所增长。* 根据LSEG的数据，13位分析师的平均预期显示，这家总部位于加利福尼亚州圣卡洛斯的公司预计将实现营收139.2万美元。* LSEG 分析师对 Iovance Biotherapeutics Inc 的平均预期是每股亏损 43 美分。* 华尔街对 Iovance Biotherapeutics Inc 的 12 个月目标价中位数为 24.50 美元，高于其上次收盘价 15.77 美元。2月26日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2414483359","title":"Iovance Biotherapeutics Inc盘中异动 早盘大幅拉升5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2414483359","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2414483359?lang=zh_cn&edition=full","pubTime":"2024-02-26 22:45","pubTimestamp":1708958742,"startTime":"0","endTime":"0","summary":"北京时间2024年02月26日22时45分，Iovance Biotherapeutics Inc股票出现异动，股价快速上涨5.45%。Iovance Biotherapeutics Inc股票所在的生物技术行业中，整体涨幅为0.26%。Iovance Biotherapeutics Inc公司简介：Iovance Biotherapeutics Inc 是一家临床阶段的生物制药公司，通过利用人体免疫系统识别和破坏多种癌细胞的能力，采用针对每位患者的个性化疗法，开创了治疗癌症的变革性方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402262245427a46ee9e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402262245427a46ee9e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2413337751","title":"Iovance Biotherapeutics Inc   预计每股亏损43美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2413337751","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2413337751?lang=zh_cn&edition=full","pubTime":"2024-02-23 19:09","pubTimestamp":1708686555,"startTime":"0","endTime":"0","summary":"   * Iovance Biotherapeutics Inc    将于2月28日公布截至2023年12月31日的财报，预计该公司的季度收入将有所增长。* 根据LSEG的数据，13位分析师的平均预期显示，这家总部位于加利福尼亚州圣卡洛斯的公司预计将实现营收139.1万美元。* LSEG 分析师对 Iovance Biotherapeutics Inc 的平均预期是每股亏损 43 美分。* 华尔街对 Iovance Biotherapeutics Inc 的 12 个月目标价中位数为 24.50 美元，高于其上次收盘价 15.94 美元。2月23日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.iovance.com","stockEarnings":[{"period":"1week","weight":0.171},{"period":"1month","weight":-0.0271},{"period":"3month","weight":0.7253},{"period":"6month","weight":2.2375},{"period":"1year","weight":0.9898},{"period":"ytd","weight":0.6765}],"compareEarnings":[{"period":"1week","weight":0.006},{"period":"1month","weight":-0.0156},{"period":"3month","weight":0.0343},{"period":"6month","weight":0.1762},{"period":"1year","weight":0.262},{"period":"ytd","weight":0.0757}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Iovance Biotherapeutics, Inc.是一家新兴的生物技术公司，专注于培养细胞，使用自体肿瘤浸润淋巴细胞（TIL）治疗转移性黑色素瘤等实体瘤的细胞治疗方法的发展和商业化。该公司于2007年9月17日在内华达州成立。","yearOnYearQuotes":[{"month":1,"riseRate":0.444444,"avgChangeRate":0.066181},{"month":2,"riseRate":0.555556,"avgChangeRate":0.167188},{"month":3,"riseRate":0.2,"avgChangeRate":-0.027658},{"month":4,"riseRate":0.3,"avgChangeRate":-0.022763},{"month":5,"riseRate":0.5,"avgChangeRate":-0.008751},{"month":6,"riseRate":0.555556,"avgChangeRate":0.188177},{"month":7,"riseRate":0.666667,"avgChangeRate":-0.007291},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.02285},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.0719},{"month":10,"riseRate":0.444444,"avgChangeRate":-0.029093},{"month":11,"riseRate":0.777778,"avgChangeRate":0.070069},{"month":12,"riseRate":0.666667,"avgChangeRate":0.07448}],"exchange":"NASDAQ","name":"Iovance Biotherapeutics, Inc.","nameEN":"Iovance Biotherapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Iovance Biotherapeutics, Inc.(IOVA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Iovance Biotherapeutics, Inc.(IOVA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Iovance Biotherapeutics, Inc.,IOVA,Iovance Biotherapeutics, Inc.股票,Iovance Biotherapeutics, Inc.股票老虎,Iovance Biotherapeutics, Inc.股票老虎国际,Iovance Biotherapeutics, Inc.行情,Iovance Biotherapeutics, Inc.股票行情,Iovance Biotherapeutics, Inc.股价,Iovance Biotherapeutics, Inc.股市,Iovance Biotherapeutics, Inc.股票价格,Iovance Biotherapeutics, Inc.股票交易,Iovance Biotherapeutics, Inc.股票购买,Iovance Biotherapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Iovance Biotherapeutics, Inc.(IOVA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Iovance Biotherapeutics, Inc.(IOVA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}